Dr. Ruben Laukkonen

Dr. Ruben Laukkonen is a Senior Lecturer (US: Associate Professor) in cognitive science and computational neuroscience. His research is theoretically driven and traverses many levels, from neurons to psychology. Key topics include meditation, insight, consciousness, and artificial minds. He serves as a chief investigator on Australia's largest psychedelic clinical trial, supported by approximately $4M from the Medical Research Future Fund (MRFF) and the Peregrine Foundation. His work has been featured in The New York Times, TIME, TEDx, Vice, ABC, Aeon, VOX, New Scientist, and in the Nature collection.